Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Growing popularity of virtual biotechs promises boon to outsourcers
Fierce CRO
Thursday, March 22, 2012 - 12:16pm
tags:
outsourcing, virtual biotech, Shire, FerroKin, Stromedix, Biogen Idec
Is AZ aiming for a Forest buy?
Fierce Pharma
Thursday, March 22, 2012 - 12:14pm
tags:
AstraZeneca, Forest Labs, M&A
Don't Get Too Worked Up Over Johnson & Johnson's Earnings
Motley Fool
Thursday, March 22, 2012 - 12:11pm
tags:
earnings, JNJ
10 Biotech Stocks Positively Correlated To Volatility
Seeking Alpha
Thursday, March 22, 2012 - 11:35am
tags:
Amyris, Aveo, China Biologic, Chelsea Therapeutics, Pluristem, Spectrum Pharmaceuticals, Questcor, Theravance, Vical, Zalicus
Corcept Therapeutics' Korlym to ship to patients by April 11
Yahoo/Fly on the Wall
Thursday, March 22, 2012 - 11:32am
tags:
Corcept Therapeutics, Korlym, Cushing's syndrome
Research shows Merck's prospective flushing drug may have another use: preventing baldness
NJ.com
Thursday, March 22, 2012 - 11:29am
tags:
Merck, baldness, Actelion
Next big cholesterol drugs in focus at meeting
Reuters
Thursday, March 22, 2012 - 11:28am
tags:
cardiology, PCSK9 inhibitor, REGN 727, Amgen, Merck, Regeneron
Icagen gets a new name after being acquired by Pfizer
News and Observer, NC
Thursday, March 22, 2012 - 11:27am
tags:
Pfizer, M&A, Icagen, Neusentis
Watson Buying Actavis? What The Wags Say…
Pharmalot
Thursday, March 22, 2012 - 11:26am
tags:
Watson, M&A, Actavis
Pozen rises as ulcer drug meets goals in studies
Yahoo/AP
Thursday, March 22, 2012 - 11:24am
tags:
ulcers, Pozen, PA32540
AstraZeneca Faces a Significant Loss of Protection
Wall St. Cheat Sheet
Thursday, March 22, 2012 - 11:23am
tags:
AstraZeneca, Seroquel XR, generics, United Kingdom
Advisory Panel Pans Drug, Investors Shrug?
Motley Fool
Thursday, March 22, 2012 - 11:09am
tags:
FDA, advisory panels, investors, ridaforolimus, Ariad Pharmaceuticals, Merck
GSK confirms $800 mln UK manufacturing investment
Reuters
Thursday, March 22, 2012 - 11:07am
tags:
GSK, United Kingdom, drug manufacturing
Pharma sales execs: Current model is broken; changes are coming
Fierce Pharma
Wednesday, March 21, 2012 - 11:59am
tags:
pharma sales
Talon Therapeutics: FDA Panel Live Blog
TheStreet.com
Wednesday, March 21, 2012 - 11:57am
tags:
FDA, advisory panel, Talon Therapeutics, Marqibo, acute lymphoblastic leukemia
Galena Biopharma's Patent Creates Both Immediate And Long-Term Upside
Seeking Alpha
Wednesday, March 21, 2012 - 11:56am
tags:
Galena Biopharma, patents, NeuVax, breast cancer
Drugmaker Teva to move listing to NYSE from Nasdaq
Reuters
Wednesday, March 21, 2012 - 11:46am
tags:
Teva Pharmaceuticals, NASDAQ, NYSE
J&J Unit Closes Facebook Page Due To Comments
Pharmalot
Wednesday, March 21, 2012 - 11:26am
tags:
JNJ, social media, Facebook
Abbott Picks AbbVie as Name for Pharmaceutical Company Spinoff
Bloomberg
Wednesday, March 21, 2012 - 11:25am
tags:
Abbott Laboratories, AbbVie, spinoff
Nothing About Targacept's Fundamental Story Has Changed, But It Is 30% Cheaper
Seeking Alpha
Wednesday, March 21, 2012 - 11:24am
tags:
Targacept

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.